Atlas Venture plans to explore a range of opportunities with the drug developers, including co-creation of life sciences start-ups, formation of asset-centric development projects and the translation of discoveries from academic collaborations...The Superior Court of Delaware granted in full a motion for summary judgment in a lawsuit by Emmaus Life Sciences Inc., of Torrance, Calif., against AFH Holding and Advisory LLC and Amir Heshmatpour
Bayer HealthCare Pharmaceuticals Inc., of Wayne, N.J., signed a three-year agreement with the California Institute for Quantitative Biosciences (QB3) to evaluate life sciences start-up companies with the goal of advancing early stage technologies and therapeutics
Receptos Inc., of San Diego, said it completed its initial public offering of 5.2 million shares priced at $14 apiece for proceeds of $72.8 million and granted underwriters Credit Suisse Securities LLC, Leerink Swann LLC, BMO Capital Markets and Wedbush PacGrow Life Sciences a 30-day option to purchase up to an additional 780,000 shares to cover overallotments
By Jennifer Boggs | BioWorld Today | Thursday, May 16, 2013
